Advertisement
Screener

Nektar Therapeutics (NKTR) Graph

NKTR Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $10.13M; Cost of revenue (m); Research and development $39.13M; Income tax $2.00K.
  • 2026-03-31: Revenue $10.86M; Cost of revenue (m); Research and development $35.68M; Income tax $64.00K.
  • 2025-12-31: Revenue $21.81M*; Cost of revenue $0.00*; Research and development $29.71M*; Income tax $31.00K*.
  • 2025-09-30: Revenue $11.79M; Cost of revenue $0.00; Research and development $27.25M; Income tax -$33.00K.

Revenue flow

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

NKTR revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Revenue$10.13MOperating income-$42.34MOther income, net-$100.00KResearch & development$39.13MPre-tax income-$40.30MIncome tax$2.00KNet income-$40.62M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentIncome taxNet income
2026-06-30$10.13M(m)$39.13M$2.00K-$40.62M
2026-03-31$10.86M(m)$35.68M$64.00K-$44.90M
2025-12-31$21.81M*$0.00*$29.71M*$31.00K*-$36.00M*
2025-09-30$11.79M$0.00$27.25M-$33.00K-$35.52M
2025-06-30$11.18M$0.00$29.89M-$188.00K-$41.59M
2025-03-31$10.46M$0.00$30.48M$52.00K-$50.88M
2024-09-30$24.12M$4.43M$35.03M$9.00K-$37.06M
2024-06-30$23.49M$9.74M$29.72M$46.00K-$52.36M
2024-03-31$21.64M$8.53M$27.41M-$35.00K-$36.80M
2023-09-30$24.14M$12.43M$24.07M-$61.00K-$45.84M
2023-06-30$20.50M$6.99M$29.68M-$47.00K-$51.12M
2023-03-31$21.59M$7.06M$30.47M-$63.00K-$137.02M
2022-09-30$23.63M$4.97M$33.59M-$155.00K-$59.05M
2022-06-30$21.59M$5.12M$42.74M$100.00K-$159.07M
2022-03-31$24.82M$5.32M$107.25M$126.00K-$90.39M
2021-12-31$25.01M$6.16M$99.61M(m)-$145.65M
2021-09-30$24.92M$5.31M$103.74M$112.00K-$129.71M
2021-06-30$28.33M$7.67M$101.31M$357.00K-$125.52M
2021-03-31$23.65M$5.76M$95.60M$92.00K-$122.97M
2020-12-31$23.46M$4.32M$102.72M(m)-$117.20M
2020-09-30$30.03M$5.57M$100.53M$21.00K-$108.59M
2020-06-30$48.85M$5.77M$96.44M$144.00K-$80.00M
2020-03-31$50.57M$3.81M$108.99M$200.00K-$138.65M
2019-12-31$33.86M$5.99M$110.37M(m)-$112.16M
2019-09-30$29.22M$4.93M$99.05M$99.00K-$98.58M
2019-06-30$23.32M$5.02M$106.69M$99.00K-$110.29M
2019-03-31$28.22M$5.44M$118.46M$137.00K-$119.63M
2018-12-31$39.83M$7.46M$108.88M(m)-$98.21M
2018-09-30$27.76M$4.78M$102.89M-$900.00K-$96.14M
2018-06-30$1.09B$5.52M$88.33M$3.88M$971.46M
2018-03-31$38.02M$6.65M$99.42M$265.00K-$95.79M
2017-12-31$95.47M$9.75M$81.43M(m)-$33.83M
2017-09-30$152.93M$5.67M$65.71M$202.00K$60.87M
2017-06-30$34.59M$8.99M$60.26M$99.00K-$59.87M
2017-03-31$24.73M$6.13M$61.06M$133.00K-$63.87M
2016-12-31$37.45M(m)$50.23M(m)-$42.20M
2016-09-30$36.34M(m)$51.95M$139.00K-$43.22M
2016-06-30$32.77M(m)$52.35M$127.00K-$48.60M
2016-03-31$58.88M(m)$49.27M$167.00K-$19.50M
2015-12-31$39.37M(m)$47.13M(m)-$54.14M
2015-09-30$59.95M(m)$43.23M$92.00K-$8.20M
2015-06-30$22.66M(m)$45.41M$164.00K-$52.66M
2015-03-31$108.80M(m)$47.01M$213.00K$33.82M
2014-12-31$19.55M(m)$38.49M(m)-$45.68M
2014-09-30$132.87M(m)$34.20M$248.00K$70.61M
2014-06-30$28.51M(m)$36.70M$195.00K-$32.64M
2014-03-31$19.77M(m)$38.34M$191.00K-$46.20M
2013-12-31$31.15M(m)$48.25M(m)-$47.66M
2013-09-30$60.91M(m)$43.91M$193.00K-$16.54M
2013-06-30$33.86M(m)$52.23M$205.00K-$42.75M
2013-03-31$23.00M(m)$45.62M$212.00K-$55.06M
2012-12-31$21.15M(m)$46.37M(m)-$52.93M
2012-09-30$18.41M(m)$34.02M$222.00K-$43.55M
2012-06-30$23.68M(m)$33.20M$93.00K-$34.28M
2012-03-31$17.95M(m)$35.09M$124.00K-$41.10M
2011-12-31$15.78M(m)$33.30M(m)-$37.49M
2011-09-30$27.07M(m)$31.02M$92.00K-$24.07M
2011-06-30$17.33M(m)$32.27M$60.00K-$36.38M
2011-03-31$11.30M(m)$30.18M$148.00K-$36.03M
2010-12-31$45.31M(m)$31.45M(m)-$22.58M
2010-09-30$37.92M(m)$27.72M$278.00K-$8.71M
2010-06-30$42.56M(m)$25.60M$31.00K-$517.00K
2010-03-31$33.24M(m)$23.29M$308.00K-$6.13M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentIncome taxNet income
2026-06-30$20.99M(m)$74.81M$66.00K-$85.53M
2025-06-30$21.64M$0.00$60.37M-$136.00K-$92.47M
2024-06-30$45.13M$18.27M$57.13M$11.00K-$89.17M
2023-06-30$42.09M$14.05M$60.15M-$110.00K-$188.14M
2022-06-30$46.41M$10.43M$149.99M$226.00K-$249.46M
2021-06-30$51.98M$13.42M$196.92M$449.00K-$248.49M
2020-06-30$99.42M$9.58M$205.42M$344.00K-$218.65M
2019-06-30$51.54M$10.46M$225.15M$236.00K-$229.92M
2018-06-30$1.13B$12.17M$187.76M$4.15M$875.67M
2017-06-30$59.32M(m)$121.32M$232.00K-$123.74M
2016-06-30$91.65M(m)$101.62M$294.00K-$68.10M
2015-06-30$131.46M(m)$92.42M$377.00K-$18.84M
2014-06-30$48.28M(m)$75.04M$386.00K-$78.84M
2013-06-30$56.87M(m)$97.85M$417.00K-$97.81M
2012-06-30$41.63M(m)$68.29M$217.00K-$75.38M
2011-06-30$28.63M(m)$62.45M$208.00K-$72.42M
2010-06-30$75.80M(m)$48.89M$339.00K-$6.65M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentIncome taxNet income
2025-09-30$33.42M$0.00$87.62M-$169.00K-$128.00M
2024-09-30$69.25M$22.71M$92.16M$20.00K-$126.22M
2023-09-30$66.24M$26.48M$84.22M-$171.00K-$233.98M
2022-09-30$70.03M$15.40M$183.58M$71.00K-$308.51M
2021-09-30$76.90M$18.73M$300.65M$561.00K-$378.19M
2020-09-30$129.45M$15.15M$305.95M$365.00K-$327.24M
2019-09-30$80.75M$15.38M$324.20M$335.00K-$328.50M
2018-09-30$1.15B$16.95M$290.65M$3.25M$779.52M
2017-09-30$212.25M(m)$187.03M$434.00K-$62.87M
2016-09-30$127.98M(m)$153.57M$433.00K-$111.33M
2015-09-30$191.41M(m)$135.65M$469.00K-$27.04M
2014-09-30$181.16M(m)$109.24M$634.00K-$8.23M
2013-09-30$117.78M(m)$141.76M$610.00K-$114.35M
2012-09-30$60.05M(m)$102.30M$439.00K-$118.93M
2011-09-30$55.70M(m)$93.46M$300.00K-$96.48M
2010-09-30$113.72M(m)$76.61M$617.00K-$15.36M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentIncome taxNet income
2025-12-31$55.23M$0.00$117.33M-$138.00K-$164.00M
2024-12-31$98.43M$30.69M$120.91M-$239.00K-$119.00M
2023-12-31$90.12M$33.77M$114.16M-$200.00K-$276.00M
2022-12-31$92.06M$21.64M$218.32M$3.21M-$368.00M
2021-12-31$101.91M$24.90M$400.27M$557.00K-$524.00M
2020-12-31$152.91M$19.48M$408.68M$493.00K-$444.44M
2019-12-31$114.62M$21.37M$434.57M$613.00K-$440.67M
2018-12-31$1.19B$24.41M$399.54M$1.41M$681.31M
2017-12-31$307.71M$30.55M$268.46M$616.00K-$96.69M
2016-12-31$165.44M$30.21M$203.80M$876.00K-$153.52M
2015-12-31$230.78M(m)$182.79M$506.00K-$81.18M
2014-12-31$200.71M(m)$147.73M-$512.00K-$53.92M
2013-12-31$148.92M(m)$190.01M$2.25M-$162.01M
2012-12-31$81.19M(m)$148.68M$406.00K-$171.85M
2011-12-31$71.48M(m)$126.77M$1.02M-$133.98M
2010-12-31$159.04M(m)$108.06M$881.00K-$37.94M
2009-12-31$71.93M(m)$95.11M-$253.00K-$102.52M

Similar stocks

Stock NameCountryMarket CapPE Ratio
UroGen Pharma Ltd. (URGN)$2.015B-18.42
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
Generate Biomedicines, Inc. (GENB)United States$2.052B
Biohaven Ltd. (BHVN)United States$1.990B-3.83
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Braveheart Bio, Inc. (BRVE)United States$2.106B
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89